168 related articles for article (PubMed ID: 11808851)
1. Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients.
Perini F; Morra M; Alecci M; Galloni E; Marchi M; Toso V
Neurol Sci; 2001 Aug; 22(4):289-96. PubMed ID: 11808851
[TBL] [Abstract][Full Text] [Related]
2. IL-6: an early marker for outcome in acute ischemic stroke.
Waje-Andreassen U; Kråkenes J; Ulvestad E; Thomassen L; Myhr KM; Aarseth J; Vedeler CA
Acta Neurol Scand; 2005 Jun; 111(6):360-5. PubMed ID: 15876336
[TBL] [Abstract][Full Text] [Related]
3. Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction.
Isahaya K; Yamada K; Yamatoku M; Sakurai K; Takaishi S; Kato B; Hirayama T; Hasegawa Y
J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):102-7. PubMed ID: 21215657
[TBL] [Abstract][Full Text] [Related]
4. Multiplex immunoassay characterization and species comparison of inflammation in acute and non-acute ischemic infarcts in human and mouse brain tissue.
Nguyen TV; Frye JB; Zbesko JC; Stepanovic K; Hayes M; Urzua A; Serrano G; Beach TG; Doyle KP
Acta Neuropathol Commun; 2016 Sep; 4(1):100. PubMed ID: 27600707
[TBL] [Abstract][Full Text] [Related]
5. The effect of insulin resistance on inflammatory response and oxidative stress in acute cerebral ischemia.
Ozkul A; Ayhan M; Akyol A; Turgut ET; Kadikoylu G; Yenisey C
Neuro Endocrinol Lett; 2013; 34(1):52-7. PubMed ID: 23524624
[TBL] [Abstract][Full Text] [Related]
6. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke.
Tarkowski E; Rosengren L; Blomstrand C; Wikkelsö C; Jensen C; Ekholm S; Tarkowski A
Stroke; 1995 Aug; 26(8):1393-8. PubMed ID: 7631343
[TBL] [Abstract][Full Text] [Related]
7. Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients.
Dziedzic T; Gryz EA; Turaj W; Slowik A; Szczudlik A
J Mol Neurosci; 2004; 24(2):293-8. PubMed ID: 15456942
[TBL] [Abstract][Full Text] [Related]
8. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis.
Brivet FG; Emilie D; Galanaud P
Crit Care Med; 1999 Apr; 27(4):749-55. PubMed ID: 10321665
[TBL] [Abstract][Full Text] [Related]
9. [THE RELATIONSHIP BETWEEN SERUM AND LIQUOR IL-1β, IL-6, TNFα, IL-10 LEVELS AND CLINICAL, COGNITIVE AND FUNCTIONAL CHARACTERISTICS IN ACUTE ISCHEMIC STROKE].
Kulesh AA; Kuklina EM; Shestakov VV
Klin Med (Mosk); 2016; 94(9):657-62. PubMed ID: 30296039
[TBL] [Abstract][Full Text] [Related]
10. Probable role of immunological tolerance to ischemia injury in brain.
Beridze M; Shakarishvili R; Gogokhia N
Georgian Med News; 2008 Oct; (163):30-5. PubMed ID: 18997250
[TBL] [Abstract][Full Text] [Related]
11. [Effects of electroacupuncture preconditioning on cerebral infarct volume and contents of TNF-α, IL-10 in serum of rats after cerebral ischemia-reperfusion injury].
Ye T; Zhu L; Tang Q; Li H; Wu X; Jiang Y
Zhongguo Zhen Jiu; 2017 Oct; 37(10):1093-7. PubMed ID: 29354979
[TBL] [Abstract][Full Text] [Related]
12. Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke.
Licata G; Tuttolomondo A; Di Raimondo D; Corrao S; Di Sciacca R; Pinto A
Thromb Haemost; 2009 May; 101(5):929-37. PubMed ID: 19404547
[TBL] [Abstract][Full Text] [Related]
13. SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke): A Randomized Controlled Phase 2 Trial.
Smith CJ; Hulme S; Vail A; Heal C; Parry-Jones AR; Scarth S; Hopkins K; Hoadley M; Allan SM; Rothwell NJ; Hopkins SJ; Tyrrell PJ
Stroke; 2018 May; 49(5):1210-1216. PubMed ID: 29567761
[TBL] [Abstract][Full Text] [Related]
14. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
Worthmann H; Tryc AB; Goldbecker A; Ma YT; Tountopoulou A; Hahn A; Dengler R; Lichtinghagen R; Weissenborn K
Cerebrovasc Dis; 2010; 30(1):85-92. PubMed ID: 20484906
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-19 alleviates brain injury by anti-inflammatory effects in a mice model of focal cerebral ischemia.
Xie W; Fang L; Gan S; Xuan H
Brain Res; 2016 Nov; 1650():172-177. PubMed ID: 27608956
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of interleukin-6, interleukin-10 and C-reactive protein in patients with myocardial infarction treated with primary angioplasty during a 6-month follow-up.
Karpiński Ł; Płaksej R; Derzhko R; Orda A; Witkowska M
Pol Arch Med Wewn; 2009 Mar; 119(3):115-21. PubMed ID: 19514639
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of immune capacity, infection and inflammation are associated with poor outcome and mortality after stroke - the PREDICT study.
Mengel A; Ulm L; Hotter B; Harms H; Piper SK; Grittner U; Montaner J; Meisel C; Meisel A; Hoffmann S
BMC Neurol; 2019 Jul; 19(1):148. PubMed ID: 31269910
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 may protect against progressing injury during the acute phase of ischemic stroke.
Protti GG; Gagliardi RJ; Forte WC; Sprovieri SR
Arq Neuropsiquiatr; 2013 Nov; 71(11):846-51. PubMed ID: 24394869
[TBL] [Abstract][Full Text] [Related]
19. Reduced Serum Level of Interleukin-10 is Associated with Cerebral Infarction: A Case-Control and Meta-Analysis Study.
Zhu Y; Yang H; Diao Z; Li Y; Yan C
Mol Neurobiol; 2016 May; 53(4):2698-704. PubMed ID: 26253723
[TBL] [Abstract][Full Text] [Related]
20. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke.
Vila N; Castillo J; Dávalos A; Esteve A; Planas AM; Chamorro A
Stroke; 2003 Mar; 34(3):671-5. PubMed ID: 12624290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
